Organisation paid for research Program year 2025 Source: CMS Open Payments

Valley Health System

Neither a doctor nor a teaching hospital

Research payments

$338,800

95 payments

Through program year 2025, Valley Health System is reported as receiving $338,800 in research payments, across 95 payments.

By program year

7 rows

Year	Kind	Amount	Payments
2025	Research	$11,457	8
2024	Research	$16,197	9
2023	Research	$40,458	8
2022	Research	$24,467	20
2021	Research	$36,605	14
2020	Research	$53,436	17
2019	Research	$156,181	19

Breakdown

Who paid Research payments · program years 2019–2025

LivaNova USA, Inc. $181,729 30 payments
Abbott Laboratories $86,887 37 payments
Novartis Pharmaceuticals Corporation $34,787 3 payments
Jazz Pharmaceuticals Inc. $23,911 19 payments
Smith+Nephew, Inc. $5,485 4 payments
Boston Scientific Corporation $4,500 1 payment
Penumbra, Inc. $1,500 1 payment

Studies the money was for Research payments · program years 2019–2025

PRAT-MICS Study $65,000 1 payment
Comprehensive Outcomes Registry in Subjects with Epilepsy Treated with Vagus Nerve Stimulation Therapy $42,917 15 payments
Believe APR002 Study $36,479 3 payments
Randomized, Double-Blind, Placebo-Controlled, Multicenter Trial, Assessing the Impact of Inclisiran on Major Adverse Cardiovascular Events in Participants With Established Cardiovascular Disease (Victorion-2 Prevent) $34,787 3 payments
A Long-Term Safety Study to Assess the Potential for Chronic Liver Injury in Participants Treated With Epidiolex (Cannabidiol) Oral Solution $23,911 19 payments
Comprehensive Outcomes Registry in Subjects with Epilepsy Treated with Vagus Nerve Stimulation Therapy (CORE-VNS) $20,835 7 payments
A Clinical Evaluation of Absorb BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions. $17,975 4 payments
Hemodynamic-GUIDEd Management of Heart Failure $14,743 7 payments
Supporting Patients Undergoing HIgh-Risk PCI Using a High-Flow Percutaneous Left Ventricular Support Device (SHIELD II) $10,500 3 payments
ABSORB III Randomized Controlled Trial (RCT) (ABSORB-III) $10,350 3 payments

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.